In addition, BCL-2 expression is likely to be induced by transcription factor CCAAT/enhancer binding protein α, encoded by the CEBPA gene, which is mutated in about 10% of AML patients [30,51,52]. Here, BCL2 is linked to acute myeloid leukemia.